How Is The Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Performance Outlook For The Coming Months? – Marketing Sentinel
Home  »  Business   »  How Is The Corbus Pharmaceuticals Holdings Inc. (N...

How Is The Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Performance Outlook For The Coming Months?

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) has a beta value of 1.89 and has seen 0.6 million shares traded in the last trading session. The company, currently valued at $164.10M, closed the last trade at $1.25 per share which meant it lost -$0.06 on the day or -4.58% during that session. The CRBP stock price is -668.0% off its 52-week high price of $9.60 and 27.2% above the 52-week low of $0.91. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.8 million shares traded. The 3-month trading volume is 1.90 million shares.

The consensus among analysts is that Corbus Pharmaceuticals Holdings Inc. (CRBP) is a Hold stock at the moment, with a recommendation rating of 2.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 4 out of 5 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.12.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) trade information

Sporting -4.58% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the CRBP stock price touched $1.25 or saw a rise of 5.3%. Year-to-date, Corbus Pharmaceuticals Holdings Inc. shares have moved 0.00%, while the 5-day performance has seen it change 0.81%. Over the past 30 days, the shares of Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) have changed -7.41%. Short interest in the company has seen 7.08 million shares shorted with days to cover at 5.97.

Wall Street analysts have a consensus price target for the stock at $2.05, which means that the shares’ value could jump 39.02% from current levels. The projected low price target is $1.40 while the price target rests at a high of $3.00. In that case, then, we find that the current price level is -140.0% off the targeted high while a plunge would see the stock gain -12.0% from current levels.

Corbus Pharmaceuticals Holdings Inc. (CRBP) estimates and forecasts

Figures show that Corbus Pharmaceuticals Holdings Inc. shares have outperformed across the wider relevant industry. The company’s shares have lost -32.80% over the past 6 months, with this year growth rate of 64.08%, compared to 18.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 76.90% and 73.80% for the next quarter. Revenue growth from the last financial year stood is estimated to be -43.60%.

4 analysts offering their estimates for the company have set an average revenue estimate of $137k for the current quarter. 3 have an estimated revenue figure of $650k for the next quarter concluding in Sep 2021. Year-ago sales stood $286k and $1.23 million respectively for this quarter and the next, and analysts expect sales will shrink by -52.10% for the current quarter and -47.20% for the next.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -38.20% over the past 5 years.

CRBP Dividends

Corbus Pharmaceuticals Holdings Inc. is expected to release its next earnings report between August 04 and August 09 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s Major holders

Insiders own 0.42% of the company shares, while shares held by institutions stand at 44.62% with a share float percentage of 44.81%. Investors are also buoyed by the number of investors in a company, with Corbus Pharmaceuticals Holdings Inc. having a total of 128 institutions that hold shares in the company. The top two institutional holders are ETF Managers Group, LLC with over 14.11 million shares worth more than $25.82 million. As of Jun 29, 2021, ETF Managers Group, LLC held 11.27% of shares outstanding.

The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 5.46 million shares as of Jun 29, 2021. The firm’s total holdings are worth over $10.0 million and represent 4.36% of shares outstanding.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also the top two Mutual Funds that are holding company’s shares are ETF Managers Tr-EFTMG Alternative Harvest ETF and Global X Fds-The Global X Cannabis ETF. As of Jun 29, 2021, the former fund manager holds about 11.27% shares in the company for having 14.11 million shares of worth $25.82 million while later fund manager owns 4.15 million shares of worth $7.6 million as of Jun 29, 2021, which makes it owner of about 3.31% of company’s outstanding stock.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam